Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 7:2022:3495966.
doi: 10.1155/2022/3495966. eCollection 2022.

Investigation on the Inhibitory Effect of Methotrexate on Rheumatoid Synovitis via the TLR4-NF- κ B Pathway in a Rat Model

Affiliations

Investigation on the Inhibitory Effect of Methotrexate on Rheumatoid Synovitis via the TLR4-NF- κ B Pathway in a Rat Model

Xiaogang Zhang et al. Contrast Media Mol Imaging. .

Retraction in

Abstract

Rheumatoid arthritis (RA) is a rheumatoid immune system disease characterized by joint inflammation, resulting in synovial hyperplasia, articular cartilage damage or distortion, and extra-articular involvement. The morbidity is higher and the treatments are not effective in clinical, and also no unified to the pathogenesis of such diseases. The aim of this paper is to establish a rat model of rheumatoid synovitis and observe the inhibitory effect of methotrexate on this disease. A total of 100 SD rats are selected and randomly divided into 5 groups, with 20 rats in each group. The cold and damp factors of rheumatoid arthritis are induced by cold water and the arthritis score is used to verify the model. ELISA is used to measure the protein expression of Toll-like Receptor 4 (TLR4), Nuclear Factor kappa-B (NF-κB) and inflammation-related factors, and SPSS25.0 is used for statistical analysis. The results show that there is no significant difference in inflammatory scores among the four groups except the control group. However, after 3 months of intervention, the inflammatory scores in the methotrexate groups are significantly lower than those in the model group, and in the methotrexate group, the higher the dose, the lower the inflammatory scores. The experimental results show that the messenger ribonucleic acid (mRNA) and protein expressions of TLR4 and NF-κB from high to low are in the order of model group > low dose > middle dose > high dose > control group, and the expression trend of inflammation-related factors is the same as mentioned above. These results indicate that methotrexate can repair rheumatoid synovitis by inhibiting the inflammatory signaling pathway TLR4-NF-κB.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
The degree of foot swelling of rats in each group after modeling: (a) the images of the feet of rats in control group; (b) the images of the feet of rats in model group; (c) the images of the feet of rats in low dose group; (d) the images of the feet of rats in medium dose group; and (e) the images of the feet of rats in high dose group.
Figure 2
Figure 2
Synovial structure of rats in each group: (a) synovial tissue structures of the rats in control group; (b) synovial tissue structures of the rats in model group; (c) synovial tissue structures of the rats in low dose group; (d) synovial tissue structures of the rats in medium dose group; and (e) synovial tissue structures of the rats in high dose group.

References

    1. Dai Y., Wang W., Yu Y., Hu S. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management. Clinical Rheumatology . 2021;40(4):1211–1220. doi: 10.1007/s10067-020-05320-z. - DOI - PubMed
    1. Gioia C., Lucchino B., Tarsitano M. G., Iannuccelli C., Di Franco M. Dietary habits and nutrition in rheumatoid arthritis: can diet influence disease development and clinical manifestations? Nutrients . 2020;12(5):1456–1525. doi: 10.3390/nu12051456. - DOI - PMC - PubMed
    1. Testa D., Calvacchi S., Petrelli F., et al. One year in review 2021: pathogenesis of rheumatoid arthritis. Clinical & Experimental Rheumatology . 2021;39(3):445–452. doi: 10.55563/clinexprheumatol/j1l5l3. - DOI - PubMed
    1. Radu A. F., Bungau S. G. Management of rheumatoid arthritis: an overview. Cells . 2021;10(11):2857–2933. doi: 10.3390/cells10112857. - DOI - PMC - PubMed
    1. Li L., Pan Z., Ning D., Fu Y. Rosmanol and carnosol synergistically alleviate rheumatoid arthritis through inhibiting TLR4/NF-κB/MAPK pathway. Molecules . 2021;27(1):78–12. doi: 10.3390/molecules27010078. - DOI - PMC - PubMed

Publication types